Long-Term Hepatitis C Internal Ribosome Entry Site-Dependent Gene Expression Mediated by Phage Phi C31 Integrase in Mouse Model

Zhidong Sun,Yi Wang,Qiuxia Fu,Yong Zhou,Shuaizheng Jia,Juan Du,Jianchun Peng,Yingli Wang,Shuhua Yang,Linsheng Zhan

DOI: https://doi.org/10.1177/135965350901400318

2008-01-01

Antiviral Therapy

Abstract:Background: The lack of a robust small animal model for hepatitis C virus (HCV) has hindered the development of novel drugs, including internal ribosome entry site (IRES) inhibitors. Phage phi C31 integrase has emerged as a potent tool for achieving long-term gene expression in vivo. This study utilized phi C31 integrase to develop a stable, reproducible and easily accessible HCV IRES mouse model.Methods: phi C31 integrase plasmid and the reporter vector, HCV-IRES-luciferase expression cassette (containing an attB site), was codelivered to murine livers using high pressure tail vein injection. HCV IRES-dependent translation reflected by luciferase expression was accurately monitored in vivo by bioluminescence imaging. Genomic integration of the transgene was confirmed by partial hepatectomy and nested PCR. An HCV IRES-targeted short hairpin RNA (shRNA) expression plasmid, sh184, was hydrodynamically transfected into mouse liver to study its inhibition efficacy in vivo.Results: phi C31 integrase mediated intramolecular recombination between wild-type attB and attP sites in mice. The expression of luciferase was stable after 30 days post-transfection and remained so for 300 days only in the livers of mice that were coinjected with the integrase-encoding plasmid. Luciferase levels reduced dramatically after hydrodynamic transfection of sh184.Conclusions: These results indicate that this mouse model provides a powerful tool for accurate and long-term evaluation of potential anti-IRES compounds in vivo.